{"transactions":[{"id":781932,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-12T20:30:23.000Z","date":"2026-05-09","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":54000,"derivative":{"exercise_price":1.58,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001830059-26-000004","document":"form4-05122026_040519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000183005926000004/form4-05122026_040519.xml","form_type":"4"}},{"id":915678,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-06T21:30:27.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 4, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":72000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001830059-26-000002","document":"form4-02062026_040221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000183005926000002/form4-02062026_040221.xml","form_type":"4"}},{"id":1155875,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:21.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":1639,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":1639,"derivative":{"exercise_price":0.45,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":1639},"source":{"system":"sec-edgar","filing":"0001415889-25-012293","document":"form4-05072025_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012293/form4-05072025_080516.xml","form_type":"4"}},{"id":1155874,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:21.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1639,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 1,639 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 1,639 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":1639},"source":{"system":"sec-edgar","filing":"0001415889-25-012293","document":"form4-05072025_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012293/form4-05072025_080516.xml","form_type":"4"}},{"id":1278301,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-07T21:15:13.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":306750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":306750,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":306750},"source":{"system":"sec-edgar","filing":"0001415889-25-003345","document":"form4-02072025_040208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925003345/form4-02072025_040208.xml","form_type":"4"}},{"id":1322538,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-23T21:15:11.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":286899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date."}],"balance_after":286899,"derivative":{"exercise_price":0.24,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":286899},"source":{"system":"sec-edgar","filing":"0001415889-24-030058","document":"form4-12232024_041207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924030058/form4-12232024_041207.xml","form_type":"4"}},{"id":1413460,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-05T20:35:08.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":250000,"derivative":{"exercise_price":0.47,"expiration_date":"2034-09-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001415889-24-022926","document":"form4-09052024_040905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924022926/form4-09052024_040905.xml","form_type":"4"}},{"id":1652959,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-08T21:47:37.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":169000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":169000,"derivative":{"exercise_price":1.22,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":169000},"source":{"system":"sec-edgar","filing":"0001415889-24-003013","document":"form4-02082024_090230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924003013/form4-02082024_090230.xml","form_type":"4"}},{"id":1708662,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Series B Warrants (right to buy)","published_at":"2023-12-15T13:19:33.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":1639,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,639 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 1,639 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":1639,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":1639},"source":{"system":"sec-edgar","filing":"0001209191-23-058714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058714/doc4.xml","form_type":"4"}},{"id":1708661,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Series A  Warrants (right to buy)","published_at":"2023-12-15T13:19:33.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":1639,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,639 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 1,639 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":1639,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":1639},"source":{"system":"sec-edgar","filing":"0001209191-23-058714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058714/doc4.xml","form_type":"4"}},{"id":1708660,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Common Stock","published_at":"2023-12-15T13:19:33.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":1639,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,639 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 1,639 shares of common stock."}],"balance_after":101369,"source":{"system":"sec-edgar","filing":"0001209191-23-058714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058714/doc4.xml","form_type":"4"}},{"id":1844831,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-23T22:26:47.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":77600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":77600,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":77600},"source":{"system":"sec-edgar","filing":"0001209191-23-039507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123039507/doc4.xml","form_type":"4"}},{"id":1917793,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-18T21:02:41.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":1.22,"expiration_date":"2033-04-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-024695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123024695/doc4.xml","form_type":"4"}},{"id":2132147,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-25T20:34:44.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":62826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":62826,"derivative":{"exercise_price":1.48,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":62826},"source":{"system":"sec-edgar","filing":"0001209191-22-054509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122054509/doc4.xml","form_type":"4"}},{"id":2179043,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Common Stock","published_at":"2022-08-18T20:10:35.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":526,"price":1.9,"value":999.4,"ownership":{"direct":true},"balance_after":99730,"source":{"system":"sec-edgar","filing":"0001209191-22-046603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122046603/doc4.xml","form_type":"4"}},{"id":2277183,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-09T20:25:31.000Z","date":"2022-05-05","kind":"exercise","acquired":false,"shares":26204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments commencing June 7, 2018, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":1171,"derivative":{"exercise_price":1.0685,"expiration_date":"2028-11-11","underlying":"Common Stock","underlying_shares":26204},"source":{"system":"sec-edgar","filing":"0001209191-22-027840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122027840/doc4.xml","form_type":"4"}},{"id":2277182,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Common Stock","published_at":"2022-05-09T20:25:31.000Z","date":"2022-05-05","kind":"exercise","acquired":true,"shares":26204,"price":1.0685,"value":27998.974,"ownership":{"direct":true},"balance_after":99204,"source":{"system":"sec-edgar","filing":"0001209191-22-027840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122027840/doc4.xml","form_type":"4"}},{"id":2387312,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-17T21:38:47.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":62500,"derivative":{"exercise_price":4.28,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-22-010792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122010792/doc4.xml","form_type":"4"}},{"id":2616652,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-03T20:59:47.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":22082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option shall vest on the date six months after August 3, 2021, subject to the Reporting Person continuing to provide service through such date."}],"balance_after":83582,"derivative":{"exercise_price":1.0685,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":22082},"source":{"system":"sec-edgar","filing":"0001209191-21-049380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919121049380/doc4.xml","form_type":"4"}},{"id":2619639,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47898,"kind":"person","name":"Lamb Lawrence","position":1,"cik":"0001830059","reported_name":"Lamb Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-03T01:31:48.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":61500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the option shall vest in   equal monthly installments commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":61500,"derivative":{"exercise_price":10,"expiration_date":"2031-07-29","underlying":"Common Stock","underlying_shares":61500},"source":{"system":"sec-edgar","filing":"0001209191-21-049159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919121049159/doc4.xml","form_type":"4"}}]}